Abstract:INTRODUCTION:X-ray crystallography plays an important role in structure-based drug design (SBDD), and accurate analysis of crystal structures of target macromolecules and macromolecule-ligand complexes is critical at all stages. However, whereas there has been significant progress in improving methods of structural biology, particularly in X-ray crystallography, corresponding progress in the development of computational methods (such as in silico high-throughput screening) is still on the horizon. Crystal structures can be overinterpreted and thus bias hypotheses and follow-up experiments. As in any experimental science, the models of macromolecular structures derived from X-ray diffraction data have their limitations, which need to be critically evaluated and well understood for structure-based drug discovery.AREAS COVERED:This review describes how the validity, accuracy and precision of a protein or nucleic acid structure determined by X-ray crystallography can be evaluated from three different perspectives: i) the nature of the diffraction experiment; ii) the interpretation of an electron density map; and iii) the interpretation of the structural model in terms of function and mechanism. The strategies to optimally exploit a macromolecular structure are also discussed in the context of 'Big Data' analysis, biochemical experimental design and structure-based drug discovery.EXPERT OPINION:Although X-ray crystallography is one of the most detailed 'microscopes' available today for examining macromolecular structures, the authors would like to re-emphasize that such structures are only simplified models of the target macromolecules. The authors also wish to reinforce the idea that a structure should not be thought of as a set of precise coordinates but rather as a framework for generating hypotheses to be explored. Numerous biochemical and biophysical experiments, including new diffraction experiments, can and should be performed to verify or falsify these hypotheses. X-ray crystallography will find its future application in drug discovery by the development of specific tools that would allow realistic interpretation of the outcome coordinates and/or support testing of these hypotheses.

Sensitive Detection of Structural Differences using a Statistical Framework for Comparative Crystallography

Statistical analysis of crystallization database links protein physico-chemical features with crystallization mechanisms

The Future of Crystallography in Drug Discovery.

Combining molecular dynamics simulations with small-angle X-ray and neutron scattering data to study multi-domain proteins in solution.

A comparative study on the diffraction quality of protein crystals obtained using the cross-diffusion microbatch and sitting-drop vapor diffusion methods

Robust crystal structure identification at extreme conditions using a density-independent spectral descriptor and supervised learning

Cryo-electron Microscopy and X-ray Crystallography: Complementary Approaches to Structural Biology and Drug Discovery

Linking Crystallographic Model and Data Quality

A Confidence Measure for Model Fitting with X-Ray Crystallography Data

Self-Supervised Deep Learning for Model Correction in the Computational Crystallography Toolbox

Perspective: Structure determination of protein-ligand complexes at room temperature using X-ray diffraction approaches

Functional Protein Dynamics in a Crystal

MatchMaps: Non-isomorphous difference maps for X-ray crystallography

Measuring and modeling diffuse scattering in protein X-ray crystallography

Uncovering Protein Ensembles: Automated Multiconformer Model Building for X-ray Crystallography and Cryo-EM

Crystal Structure Assignment for Unknown Compounds from X-ray Diffraction Patterns with Deep Learning

Denoising Reveals Low-Occupancy Populations in Protein Crystals

Utilizing anomalous signals for element identification in macromolecular crystallography

MD-assisted Refinement of X-Ray Coordinates

Automated multiconformer model building for X-ray crystallography and cryo-EM

A Robust Crystal Structure Prediction Method to Support Small Molecule Drug Development with Large Scale Validation and Prospective Studies